Published • loading... • Updated
Spherix Global Insights Finds Icotyde Poised to More Than Double Share as New Oral Therapy May ...
Summary by Enid News & Eagle
1 Articles
1 Articles
Spherix Global Insights Finds Icotyde Poised to More Than Double Share as New Oral Therapy May ...
Exton, PA, Oct. 29, 2026 (GLOBE NEWSWIRE) -- New research from Spherix Global Insights indicates that Johnson & Johnson's Icotyde (icotrokinra) is gaining ground in the U.S. plaque psoriasis market, expanding the role of oral advanced therapies and potentially delaying…
Coverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
